Cognitive & Neurotrophic · Research deep dive
Selank: the cited literature
Every study referenced in the Selank monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, Selank is studied at 250 mcg – 750 mcg per administration, typically once or twice daily. The reference walkthrough below maps each citation to what it actually showed.
References covered
Selank, an anxiolytic peptide
Bull. Exp. Biol. Med., 2008
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for Selank.